(S)-crizotinib is an active pharmaceutical ingredient used in the manufacturing of anticancer medications. It functions as a tyrosine kinase inhibitor targeting c-Met/HGFR, ALK, and ROS1, primarily for research and pharmaceutical production related to non-small cell lung carcinoma.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1374356-45-2
4-[4-[6-Amino-5-[[(R)-1-(2,6-dichloro-3-fluorophenyl)ethyl]oxy]pyridin-3-yl]pyrazol-1-yl]piperidine-1-carboxylic acid tert-butyl ester
pharmaceutical intermediate
Ribociclib succinate
pharmaceutical raw material
Rociletinib
pharmaceutical raw material
Trilaciclib
pharmaceutical raw material
NB-124 sulfate
pharmaceutical raw material
Crizotinib
pharmaceutical raw material
3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
KTEIFNKAUNYNJU-LBPRGKRZSA-N
C[C@@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N